title: Unexpected occurrence of adrenal Cushing's syndrome in a patient with systemic lupus erythematosus.
authors.forename: Akihiro
authors.initials: A
authors.lastname: Katayama
authors.forename: Fumio
authors.initials: F
authors.lastname: Otsuka
authors.forename: Katsuyuki
authors.initials: K
authors.lastname: Tanabe
authors.forename: Naoko
authors.initials: N
authors.lastname: Tsukamoto
authors.forename: Ryutaro
authors.initials: R
authors.lastname: Yamanaka
authors.forename: Yoshinori
authors.initials: Y
authors.lastname: Matsumoto
authors.forename: Yasutomo
authors.initials: Y
authors.lastname: Nasu
authors.forename: Hirofumi
authors.initials: H
authors.lastname: Makino
mesh_terms: D000306:Adrenal Cortex Neoplasms / Q000175:diagnosis* / Q000473:pathology / Q000601:surgery; D000315:Adrenalectomy; D018246:Adrenocortical Adenoma / Q000175:diagnosis* / Q000473:pathology / Q000601:surgery; D000328:Adult; D018207:Angiomyolipoma / Q000175:diagnosis* / Q000473:pathology / Q000601:surgery; D000959:Antihypertensive Agents / Q000627:therapeutic use; D001562:Benzimidazoles / Q000627:therapeutic use; D001713:Biphenyl Compounds; D003480:Cushing Syndrome / Q000139:chemically induced / Q000175:diagnosis* / Q000188:drug therapy; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008180:Lupus Erythematosus, Systemic / Q000150:complications* / Q000188:drug therapy; D009543:Nifedipine / Q000627:therapeutic use; D011239:Prednisolone / Q000627:therapeutic use; D012263:Ribonucleosides / Q000627:therapeutic use*; D013148:Spironolactone / Q000627:therapeutic use; D013777:Tetrazoles / Q000627:therapeutic use
chemical_list: D000959:Antihypertensive Agents; D001562:Benzimidazoles; D001713:Biphenyl Compounds; D007166:Immunosuppressive Agents; D012263:Ribonucleosides; D013777:Tetrazoles; D013148:Spironolactone; C010052:mizoribine; D011239:Prednisolone; D009543:Nifedipine; C081643:candesartan